Quoin Pharmaceuticals (NASDAQ:QNRX) reported quarterly losses of $(0.41) per share which beat the analyst consensus estimate of $(0.62) by 33.87 percent.
Morgan Stanley Maintains Underweight on Citigroup, Lowers Price Target to $46
Morgan Stanley analyst Betsy Graseck maintains Citigroup (NYSE:C) with a Underweight and lowers the price target from $57 to $46.